
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PRRG1 CRISPR/Cas9 KO Plasmid (m) | sc-436837 | 20 µg | $397.00 |
Mouse Prrg1 encodes PRRG1, a proline-rich transmembrane protein with a γ-carboxyglutamate (Gla) domain that suggests roles in calcium-dependent protein interactions at the cell surface. PRRG1 is implicated in adhesion-associated signaling and membrane-proximal regulatory processes that can influence cytoskeletal organization, receptor trafficking, and communication between the extracellular matrix and intracellular pathways. Expression patterns and reported associations link PRRG1 to cellular differentiation programs and tissue-specific homeostasis, making it relevant for studies of signaling perturbations in developmental and disease-related contexts. Dissecting PRRG1 function can help clarify how Gla-domain proteins modulate local signaling microenvironments and downstream transcriptional responses.
PRRG1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Prrg1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Prrg1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Prrg1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PRRG1 protein expression.
This CRISPR knockout system enables efficient generation of Prrg1-deficient cell models for investigation of PRRG1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.